🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Blastic Plasmacytoid Dendritic Cell Neoplasm

Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies NCT07523555Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: Autologous CD19/CD22 dual-target CAR-T module, Autologous CD19/CD20 dual-target CAR-T module, Autologous BCMA/CD19 dual… Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients NCT07007052Phase 234 sites📍 Amiens📍 Angers📍 Argenteuil French Innovative Leukemia Organisation · Tests: Venetoclax, Tagraxofusp A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy NCT07785180n/a67 sites📍 Aarhus📍 Odense📍 Besançon Stemline Therapeutics, Inc. · Tests: Chemotherapy Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm NCT04216524Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin, Mercaptopurine CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) NCT04318678Phase 12 sites📍 Memphis📍 Memphis St. Jude Children's Research Hospital · Tests: CD123-CAR T, Cyclophosphamide, Fludarabine, Mesna, Rituximab SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) NCT03113643Phase 13 sites📍 Duarte📍 Boston📍 Houston Dana-Farber Cancer Institute · Tests: Azacitidine, SL-401, Venetoclax Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies NCT05476770Phase 131 sites📍 Los Angeles📍 Orange📍 San Francisco Therapeutic Advances in Childhood Leukemia Consortium · Tests: Tagraxofusp, Fludarabine, Cytarabine, Dexamethasone, Vincristine Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810Phase 12 sites📍 Scottsdale📍 Rochester Mayo Clinic · Tests: Axl/Mer/CSF1R Inhibitor Q702, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry NCT05430971n/a22 sites📍 Miami📍 Tampa📍 Seattle Immune Oncology Research Institute HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant NCT03326921Phase 11 site📍 Seattle Fred Hutchinson Cancer Center · Tests: CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR, Bone Marrow Aspiration, Biospecimen Collection Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases NCT06013423Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Biospecimen Collection, Bone Marrow Aspirate, Cyclophosphamide, Cyclosporine, Diagnostic Imaging Testing CARCIK CD123/33 for Refractory/Relapsed AML and BPDCN in Children and Adults NCT07877610Phase 1, Phase 22 sites📍 Monza📍 Bergamo Fondazione Matilde Tettamanti Menotti De Marchi Onlus · Tests: CARCIK CD123/33 infusion Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCN NCT06690827Phase 11 site📍 Wuhan Chongqing Precision Biotech Co., Ltd · Tests: Anti-CD123 CAR NK cells A Registry-study of ELZONRIS in Participants With BPDCN NCT07785154n/a41 sites📍 Innsbruck📍 Linz📍 Salzburg Stemline Therapeutics, Inc. · Tests: Tagraxofusp
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy